{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:06:32Z","timestamp":1774983992194,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1983,10,1]],"date-time":"1983-10-01T00:00:00Z","timestamp":433814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1983,10,1]],"date-time":"1983-10-01T00:00:00Z","timestamp":433814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1983,10]]},"DOI":"10.1016\/0002-9343(83)90141-9","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T23:43:28Z","timestamp":1082418208000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"P1","title":["Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies"],"prefix":"10.1016","volume":"75","author":[{"given":"Daniel J.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.David","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas D.","family":"Vlachakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward D.","family":"Preis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald G.","family":"Vidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L.","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert G.","family":"Langford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Flamenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia P.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0002-9343(83)90141-9_BIB1","first-page":"721","article-title":"Pharmacologic effects of labetalol in man","volume":"3","author":"Richards","year":"1976","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.CIR.55.2.370","article-title":"Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent in hypertensive subjects","volume":"55","author":"Mehta","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/0002-9343(83)90141-9_BIB3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/hrt.39.1.99","article-title":"Pharmacological bases for antihypertensive effects of intravenous labetalol","volume":"39","author":"Richards","year":"1977","journal-title":"Br Heart J"},{"key":"10.1016\/0002-9343(83)90141-9_BIB4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00562897","article-title":"Relationship between plasma concentrations and pharmacological effects of labetalol","volume":"11","author":"Richards","year":"1977","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB5","first-page":"1059","article-title":"Antihypertensive effects of labetalol (Sch 15719W, AH 5158A)","volume":"36","author":"Johnson","year":"1977"},{"key":"10.1016\/0002-9343(83)90141-9_BIB6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1476-5381.1980.tb07934.x","article-title":"Director vasodilatation by labetalol in anesthetized dogs","volume":"70","author":"Dage","year":"1980","journal-title":"Br J Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3565(25)32690-X","article-title":"Antihypertensive and hemodynamic actions of Sch 19927, the R,R-isomer of labetalol","volume":"218","author":"Baum","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/0002-9343(83)90141-9_BIB8","doi-asserted-by":"crossref","first-page":"107S","DOI":"10.1111\/j.1365-2125.1979.tb04763.x","article-title":"Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin","volume":"8","author":"Lund-Johansen","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB9","first-page":"497S","article-title":"Effect on blood pressure, angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol","volume":"51","author":"Trust","year":"1976","journal-title":"Clin Sci Mol Med"},{"key":"10.1016\/0002-9343(83)90141-9_BIB10","first-page":"139","article-title":"The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels","volume":"33","author":"Agabiti-Roei","year":"1983","journal-title":"Br J Clin Pharmacol Ther"},{"key":"10.1016\/0002-9343(83)90141-9_BIB11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2125.1979.tb04719.x","article-title":"Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension","volume":"8","author":"Cummings","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB12","doi-asserted-by":"crossref","first-page":"135S","DOI":"10.1111\/j.1365-2125.1979.tb04768.x","article-title":"Labetalol in the treatment of patients with hypertension and renal function impairment","volume":"8","author":"Bailey","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB13","doi-asserted-by":"crossref","first-page":"129S","DOI":"10.1111\/j.1365-2125.1979.tb04767.x","article-title":"Monotherapy with labetalol for hypertensive patients with normal and impaired renal function","volume":"8","author":"Thompson","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB14","doi-asserted-by":"crossref","first-page":"233S","DOI":"10.1111\/j.1365-2125.1979.tb04787.x","article-title":"Labetalol infusion in acute myocardial infarction with systemic hypertension","volume":"8","author":"Marx","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB15","doi-asserted-by":"crossref","first-page":"111S","DOI":"10.1111\/j.1365-2125.1982.tb01898.x","article-title":"Role of labetalol in acute myocardial infarction","volume":"13","author":"Timmis","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(79)91413-2","article-title":"Intravenous labetalol in hypertensive emergency","volume":"1","author":"Cummings","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/0002-9343(83)90141-9_BIB17","first-page":"65","article-title":"Preliminary clinical trial on hypotensive and antiarrhythmic effect of labetalol","volume":"7","author":"Romano","year":"1981","journal-title":"Drugs Exptl Clin Res"},{"key":"10.1016\/0002-9343(83)90141-9_BIB18","first-page":"613","article-title":"Acute antihypertensive and antiarrhythmic effects of labetalol","volume":"29","author":"Mazzola","year":"1981","journal-title":"Curr Ther Res"},{"key":"10.1016\/0002-9343(83)90141-9_BIB19","first-page":"673","article-title":"The effect of AH 5158, pindolol, propranolol, d-propranolol and acute exercise tolerance in angina pectoris","volume":"47","author":"Boakes","year":"1973","journal-title":"Br J Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB20","first-page":"199S","article-title":"Treatment of severe hypertension by repeated bolus injections of labetalol","volume":"8","author":"Cummings","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(75)90470-5","article-title":"Intravenous labetalol in severe hypertension","volume":"2","author":"Rosei","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/0002-9343(83)90141-9_BIB22","first-page":"805S","article-title":"Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension","volume":"3","author":"Ronne-Rasmussen","year":"1976","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB23","first-page":"799S","article-title":"Effect on blood pressure, angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol","volume":"3","author":"Trust","year":"1976","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB24","first-page":"47","article-title":"Diazoxide vs labetalol: a crossover comparison of short-term effects in hypertension","volume":"3","author":"Rumboldt","year":"1983","journal-title":"Int J Clin Pharm Res"},{"key":"10.1016\/0002-9343(83)90141-9_BIB25","series-title":"Pharmacological basis of therapeutics","first-page":"715","article-title":"Antihypertensive agents and the drug therapy of hypertension","author":"Nickerson","year":"1970"},{"key":"10.1016\/0002-9343(83)90141-9_BIB26","first-page":"135","article-title":"Control of severe hypertension with pulse doses of diazoxide","volume":"23","author":"Wilson","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/0002-9343(83)90141-9_BIB27","series-title":"Cardiovascular therapy","first-page":"79","article-title":"Control of severe hypertension with pulse diazoxide","author":"Wilson","year":"1982"},{"key":"10.1016\/0002-9343(83)90141-9_BIB28","series-title":"management of essential hypertension","first-page":"371","article-title":"Diazoxide\/sodium nitroprusside","author":"McMahon","year":"1978"},{"key":"10.1016\/0002-9343(83)90141-9_BIB29","doi-asserted-by":"crossref","first-page":"195S","DOI":"10.1111\/j.1365-2125.1979.tb04780.x","article-title":"Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings","volume":"8","author":"Pearson","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-9343(83)90141-9_BIB30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5694\/j.1326-5377.1978.tb107932.x","article-title":"Labetalol in hypertensive emergencies","volume":"1","author":"MacCarthy","year":"1978","journal-title":"Med J Aust"},{"key":"10.1016\/0002-9343(83)90141-9_BIB31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5694\/j.1326-5377.1978.tb76817.x","article-title":"Emergency treatment of severe hypertension with intravenous labetalol","volume":"2","author":"McGrath","year":"1978","journal-title":"Med J Aust"},{"key":"10.1016\/0002-9343(83)90141-9_BIB32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1185\/03007997809111909","article-title":"Poor hypotensive response and tachyphylaxis following intravenous labetalol","volume":"5","author":"Anderson","year":"1978","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/0002-9343(83)90141-9_BIB33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5694\/j.1326-5377.1979.tb125802.x","article-title":"Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension","volume":"2","author":"Yeung","year":"1979","journal-title":"Med J Aust"},{"key":"10.1016\/0002-9343(83)90141-9_BIB34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bmj.2.6089.737","article-title":"Pressor response after intravenous labetalol","volume":"2","author":"Crofton","year":"1977","journal-title":"Br M J"},{"key":"10.1016\/0002-9343(83)90141-9_BIB35","first-page":"795","article-title":"Intravenous labetalol in hypertensive patients treated with \u03b2-adrenergic blocking drugs","volume":"3","author":"Pearson","year":"1976","journal-title":"Br J Clin Pharmacol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002934383901419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002934383901419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T06:21:13Z","timestamp":1756880473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0002934383901419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1983,10]]}},"alternative-id":["0002934383901419"],"URL":"https:\/\/doi.org\/10.1016\/0002-9343(83)90141-9","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[1983,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-9343(83)90141-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1983 Published by Excerpta Medica Inc.","name":"copyright","label":"Copyright"}]}}